Influence of chronic ethanol consumption on the muscarinic cholinergic control of rat pancreatic acinar cells.
There are a number of hypothetical explanations for the actions of ethanol on the exocrine pancreas; among them, the cholinergic hypothesis has received special attention. According to this hypothesis, chronic alcohol consumption induces alterations in the control of exocrine pancreatic function resulting in cholinergic hyperstimulation of pancreatic acinar cells and their muscarinic receptors. Our aim was to investigate the cholinergic control of pancreatic enzyme secretion and the number and affinity of muscarinic receptors in the pancreatic acinar cells of rats subjected to chronic ethanol ingestion. We also investigated whether a high-fibre diet modifies the actions of ethanol on these aspects of the exocrine pancreatic function. Four groups of rats received either a standard or a high fibre diet, and either water or 20% (v/v) ethanol. After 6 months of treatment, isolated pancreatic acini were used for the determination of carbachol-stimulated amylase secretion and for the analysis of muscarinic receptors, using 1-[N-methyl-3H]scopolamine as a radioligand. Neither chronic ethanol intake nor a high fibre diet caused any apparent alteration in pancreatic histology, neither did them modify plasmatic amylase levels. Chronic alcoholization resulted in a significant increase in the amylase released from pancreatic acini in response to carbachol stimulation, but it did not affect either the number or the affinity of pancreatic acinar muscarinic receptors. The actions of ethanol are not significantly modified by the simultaneous consumption of a high fibre diet.
Acosta
J J
JJ
Depto de Fisilogía y Farmacología, Univ de Salamanca, Spain.
San Román
J I
JI
López
M A
MA
Calvo
J J
JJ
D000437:Alcoholism / Q000378:metabolism / Q000503:physiopathology; D000681:Amylases / Q000378:metabolism; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002478:Cells, Cultured; D002492:Central Nervous System Depressants / Q000494:pharmacology*; D018679:Cholinergic Agonists / Q000494:pharmacology; D002799:Cholinergic Fibers / Q000737:chemistry / Q000187:drug effects* / Q000502:physiology; D002908:Chronic Disease; D004043:Dietary Fiber / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D000431:Ethanol / Q000494:pharmacology*; D008297:Male; D010179:Pancreas / Q000166:cytology / Q000294:innervation* / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D011976:Receptors, Muscarinic / Q000032:analysis / Q000378:metabolism*; D012601:Scopolamine / Q000378:metabolism / Q000494:pharmacology; D012602:Scopolamine Derivatives; D014316:Tritium
D002492:Central Nervous System Depressants; D018679:Cholinergic Agonists; D004043:Dietary Fiber; D011976:Receptors, Muscarinic; D012602:Scopolamine Derivatives; D014316:Tritium; D000431:Ethanol; D002217:Carbachol; D012601:Scopolamine; D000681:Amylases